These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 10937732)
1. 6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonists. Isaac M; Slassi A; Xin T; MacLean N; Wilson J; McCallum K; Wang H; Demchyshyn L Bioorg Med Chem Lett; 2000 Aug; 10(15):1719-21. PubMed ID: 10937732 [TBL] [Abstract][Full Text] [Related]
12. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies. Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel gamma-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists. Ivachtchenko AV; Frolov EB; Mitkin OD; Kysil VM; Khvat AV; Okun IM; Tkachenko SE Bioorg Med Chem Lett; 2009 Jun; 19(12):3183-7. PubMed ID: 19443217 [TBL] [Abstract][Full Text] [Related]
14. N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists. Tsai Y; Dukat M; Slassi A; MacLean N; Demchyshyn L; Savage JE; Roth BL; Hufesein S; Lee M; Glennon RA Bioorg Med Chem Lett; 2000 Oct; 10(20):2295-9. PubMed ID: 11055342 [TBL] [Abstract][Full Text] [Related]
15. (3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: potent and selective antagonists of the serotonin 5-HT6 receptor. Ivachtchenko AV; Dmitriev DE; Golovina ES; Kadieva MG; Koryakova AG; Kysil VM; Mitkin OD; Okun IM; Tkachenko SE; Vorobiev AA J Med Chem; 2010 Jul; 53(14):5186-96. PubMed ID: 20560595 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacological activity of metabolites of the 5-HT(4) receptor antagonist SB-207266. Fedouloff M; Hossner F; Voyle M; Ranson J; Powles J; Riley G; Sanger G Bioorg Med Chem; 2001 Aug; 9(8):2119-28. PubMed ID: 11504648 [TBL] [Abstract][Full Text] [Related]
17. Optimization of (arylpiperazinylbutyl)oxindoles exhibiting selective 5-HT₇ receptor antagonist activity. Volk B; Gacsályi I; Pallagi K; Poszávácz L; Gyönös I; Szabó E; Bakó T; Spedding M; Simig G; Szénási G J Med Chem; 2011 Oct; 54(19):6657-69. PubMed ID: 21859099 [TBL] [Abstract][Full Text] [Related]
18. Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists. Bromidge SM; Clarke SE; King FD; Lovell PJ; Newman H; Riley G; Routledge C; Serafinowska HT; Smith DR; Thomas DR Bioorg Med Chem Lett; 2002 May; 12(10):1357-60. PubMed ID: 11992776 [TBL] [Abstract][Full Text] [Related]
19. 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists. Rowley M; Hallett DJ; Goodacre S; Moyes C; Crawforth J; Sparey TJ; Patel S; Marwood R; Patel S; Thomas S; Hitzel L; O'Connor D; Szeto N; Castro JL; Hutson PH; MacLeod AM J Med Chem; 2001 May; 44(10):1603-14. PubMed ID: 11334570 [TBL] [Abstract][Full Text] [Related]
20. New tetrahydrobenzindoles as potent and selective 5-HT(7) antagonists with increased In vitro metabolic stability. Kikuchi C; Suzuki H; Hiranuma T; Koyama M Bioorg Med Chem Lett; 2003 Jan; 13(1):61-4. PubMed ID: 12467617 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]